OAT PINs and DINs

The table below provides appropriate PINs and DINs for PharmaCare claims for opiate agonist therapy (OAT) treatments for opioid use disorder. PINs listed are for OAT claims only.

For more information on OAT and current methadone formulations, please see the BC Centre on Substance Use bulletin (PDF, 480 KB).

Interaction Fees

For all eligible direct interaction OAT claims, PharmaCare pays an interaction fee to pharmacies that are:

  • enrolled in the Methadone Maintenance Sub-Class; and
  • dispensing methadone with direct interaction

Plan B claims are excluded from interaction fees. Eligible claims include those for Fair PharmaCare beneficiaries who have not met their deductible.

Pain Indications

Many of the drugs listed below may be prescribed for pain. If a prescription is for pain, enter the transaction in PharmaNet with the correct DIN.

Do not use OAT PINs for pain indications.

Direct Interaction

Drug DIN/PIN for OAT Claims Plan Coverage Claim Submission Requirements
Methadose™ 10mg/mL (cherry) 66999997 (PIN)

Covered under plans:
B, C, G, P, W and Fair PharmaCare.

Maximum one dispensing fee and one interaction fee per patient per day.

Claim quantity must be submitted as total mLs.

SIG must include dose in mg & mL (e.g. Take 5mLs (50mg) once daily.)

SIG must include the start and end dates of the prescription.

Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose.

Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee.

A single interaction fee will be paid for the first witnessed dose.

Metadol-D® 10mg/mL (unflavoured) 67000005 (PIN)

Methadone (Sterinova®) 10mg/mL

67000017 (PIN)

Direct Interaction with Delivery

Drug DIN/PIN for OAT Claims Plan Coverage Claim Submission Requirements
Methadose™ 10mg/mL (cherry) 66999999 (PIN)

Covered under plans:
B, C, G, P, W and Fair PharmaCare.

Maximum one dispensing fee and one interaction fee per patient per day.

Claim quantity must be submitted as total mLs.

SIG must include dose in mg & mL (e.g. Take 5mLs (50mg) once daily.)

SIG must include the start and end dates of the prescription.

Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose.

Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee.

A single interaction fee will be paid for the first witnessed dose.

Metadol-D® 10mg/mL (unflavoured)

67000007 (PIN)

Methadone (Sterinova®) 10mg/mL

67000018 (PIN)

No Direct Interaction

Drug DIN/PIN for OAT Claims Plan Coverage Claim Submission Requirements

Methadose™ 10mg/mL (cherry)

66999998 (PIN)

Covered under plans:
B, C, G, P, W and Fair PharmaCare.

Claim quantity must be submitted as total mLs.

SIG must include dose in mg & mL (e.g. Take 5mLs (50mg) once daily.)

SIG must include the start and end dates of the prescription.

Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose.

Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee.

Metadol-D® 10mg/mL (unflavoured)

67000006 (PIN)

Methadone (Sterinova®) 10mg/mL

67000020 (PIN)

No Direct Interaction with Delivery

Drug DIN/PIN for OAT Claims Plan Coverage Claim Submission Requirements

Methadose

10mg/mL (cherry)

67000000 (PIN)

Covered under plans:
B, C, G, P, W and Fair PharmaCare.

Claim quantity must be submitted as total mLs.

SIG must include dose in mg & mL (e.g. Take 5mLs (50mg) once daily.)

SIG must include the start and end dates of the prescription.

Carries must be claimed as single multiple-day supply for drug cost, plus a single dispensing fee. A single interaction fee will be paid for the first witnessed dose.

Split doses must be claimed as a single multiple-dose claim for drug cost, plus a single dispensing fee.

Metadol-D®

10mg/mL (unflavoured)

67000008 (PIN)

Methadone (Sterinova®) 10mg/mL

67000019 (PIN)

Non-benefit Methadone

Drug DIN/PIN for OAT Claims Plan Coverage Claim Submission Requirements
Methadose™ 10mg/mL sugar-free

with direct interaction

67000001 (PIN) Non-benefit. Special Authority coverage required under plans B, C, G, P, W and Fair PharmaCare. 

See relevant dispense type above for submission requirements.

Methadose™ 10mg/mL sugar-free

delivery with direct interaction

67000003 (PIN)
Methadose™ 10mg/mL sugar-free

without direct interaction

67000002 (PIN)
Methadose™ 10mg/mL sugar-free

delivery without direct interaction

67000004 (PIN)
Compounded methadone 10mg/mL

with direct interaction

67000013 (PIN)

Non-benefit. Last-resort, exceptional coverage only. Special Authority required. Dispensing pharmacies must order compounded methadone from the central compounding pharmacy. Please contact the BCCSU or the BCPhA for details.

See relevant dispense type above for submission requirements.
Compounded methadone 10mg/mL

delivery with direct interaction

67000014 (PIN)
Compounded methadone 10mg/mL

without direct interaction

67000016 (PIN)
Compounded methadone 10mg/mL 

delivery without direct interaction

67000015 (PIN)

Buprenorphine/Naloxone, Suboxone, and Kadian DINs and PINs

Drug DIN/PIN for OAT Claims Plan Coverage Claim Submission Requirements
Buprenorphine/Naloxone SL 2mg/0.5mg generics ACT 02453908

Covered under plans B, C, G, P, W, and Fair PharmaCare.

No interaction fee paid for witnessed ingestion.

Claim quantity must be submitted as the number of tablets.

SIG should include start and end dates as best practice (not mandatory.)

PMS 02424851
Buprenorphine/Naloxone SL 8mg/2mg generics ACT 02453916
PMS 02424878
Suboxone®

Buprenorphine/Naloxone

2mg/0.5mg SL

02295695

Suboxone® is a partial benefit under plans B, C, G, P, W, and Fair PharmaCare.

No interaction fee paid for witnessed ingestion.

Claim quantity must be submitted as the number of tablets.

SIG should include start and end dates as best practice (not mandatory.)

Suboxone®

Buprenorphine/Naloxone

8mg/2mg SL

02295709
Suboxone®

Buprenorphine/Naloxone

12mg/3mg SL

02468085

Exceptional Special Authority coverage required under plans B, C, G, P, W and Fair PharmaCare.

No interaction fee paid for witnessed ingestion.

Suboxone®

Buprenorphine/Naloxone

16mg/4mg SL

02468093
Kadian® slow-release oral morphine 10mg capsule 22123349 (PIN)

Covered for OAT under plans B, C, G, P, W and Fair PharmaCare.

No interaction fee paid for witnessed ingestion.

Submit using PharmaCare PINs if for OAT.

Claim quantity must be submitted as the number of capsules.

SIG should include start and end dates as best practice (not mandatory.)

Kadian® slow-release oral morphine 20mg capsule 22123346 (PIN)
Kadian® slow-release oral morphine 50mg capsule 22123347 (PIN)
Kadian® slow-release oral morphine 100mg capsule 22123348 (PIN)